Paper33907692
TNFR2: Role in Cancer Immunology and Immunotherapy.
Yang Y and 3 others. Immunotargets Ther, 2021. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. TNFR2: Role in Cancer Immunology and Immunotherapy. Papers, record 33907692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33907692
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References189
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28187290 | Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. | Cell | 2017 | https://conductscience.org/library/papers/28187290 | PubMed |
| 2 | 23758787 | TRAF molecules in cell signaling and in human diseases. | J Mol Signal | 2013 | https://conductscience.org/library/papers/23758787 | PubMed |
| 3 | 25492937 | Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells. | J Leukoc Biol | 2015 | https://conductscience.org/library/papers/25492937 | PubMed |
| 4 | 22224781 | Regulatory T cells: mechanisms of differentiation and function. | Annu Rev Immunol | 2012 | https://conductscience.org/library/papers/22224781 | PubMed |
| 5 | 30498033 | Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30498033 | PubMed |
| 6 | 7566090 | Induction of apoptosis in mature T cells by tumour necrosis factor. | Nature | 1995 | https://conductscience.org/library/papers/7566090 | PubMed |
| 7 | 11869683 | Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. | Immunity | 2002 | https://conductscience.org/library/papers/11869683 | PubMed |
| 8 | 17878327 | CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. | J Immunol | 2007 | https://conductscience.org/library/papers/17878327 | PubMed |
| 9 | 17992258 | TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17992258 | PubMed |
| 10 | 28194435 | Foxp3 drives oxidative phosphorylation and protection from lipotoxicity. | JCI Insight | 2017 | https://conductscience.org/library/papers/28194435 | PubMed |
| 11 | 24512738 | Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera. | Immunol Lett | 2014 | https://conductscience.org/library/papers/24512738 | PubMed |
| 12 | 27586383 | Therapy: Paradoxical effects of targeting TNF signalling in the treatment of autoimmunity. | Nat Rev Rheumatol | 2016 | https://conductscience.org/library/papers/27586383 | PubMed |
| 13 | 12893750 | Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. | Blood | 2003 | https://conductscience.org/library/papers/12893750 | PubMed |
| 14 | 15528374 | Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. | J Immunol | 2004 | https://conductscience.org/library/papers/15528374 | PubMed |
| 15 | 28407145 | GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/28407145 | PubMed |
| 16 | 25977337 | Blocking Tumor Necrosis Factor α Enhances CD8 T-cell-Dependent Immunity in Experimental Melanoma. | Cancer Res | 2015 | https://conductscience.org/library/papers/25977337 | PubMed |
| 17 | 12655295 | Tumor necrosis factor signaling. | Cell Death Differ | 2003 | https://conductscience.org/library/papers/12655295 | PubMed |
| 18 | 12522256 | Control of regulatory T cell development by the transcription factor Foxp3. | Science | 2003 | https://conductscience.org/library/papers/12522256 | PubMed |
| 19 | 26268655 | Transmembrane TNF-TNFR2 Impairs Th17 Differentiation by Promoting Il2 Expression. | J Immunol | 2015 | https://conductscience.org/library/papers/26268655 | PubMed |
| 20 | 31043740 | Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy. | Nature | 2019 | https://conductscience.org/library/papers/31043740 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42717500 | SOX30 Facilitates Triple-Negative Breast Cancer Metastasis via TNFR2-NF-κB Signaling and Tumor Microenvironment Remodeling. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42717500 | PubMed |
| 41891328 | High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes. | Am J Hematol | 2026 | https://conductscience.org/library/papers/41891328 | PubMed |
| 41884420 | Systemic Immune Remodeling in Breast Cancer: Selective Enrichment of TNFR2+ Circulating Lymphocytes in Breast Cancer. | Breast Cancer (Dove Med Press) | 2026 | https://conductscience.org/library/papers/41884420 | PubMed |
| 41651411 | TNF-alpha: Roles in pathogenesis and therapeutics in cancer. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41651411 | PubMed |
| 41080584 | Multi-omics analysis reveals ultraviolet response insights for immunotherapy and prognosis. | Front Immunol | 2025 | https://conductscience.org/library/papers/41080584 | PubMed |
| 40702360 | Adipose-derived mesenchymal stromal/stem cells in type 1 diabetes treatment. | Commun Biol | 2025 | https://conductscience.org/library/papers/40702360 | PubMed |
| 40649828 | Targets for CAR Therapy in Multiple Myeloma. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40649828 | PubMed |
| 40213689 | Recent advancement in the anticancer efficacy of the natural flavonoid scutellarin: a comprehensive review. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40213689 | PubMed |
| 40079721 | Circulating Inflammation Biomarkers and the Risk of Esophageal Adenocarcinoma: A Nested Case-Control Study in the Department of Defense Serum Repository. | Cancer Epidemiol Biomarkers Prev | 2025 | https://conductscience.org/library/papers/40079721 | PubMed |
| 39609700 | Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer. | J Exp Clin Cancer Res | 2024 | https://conductscience.org/library/papers/39609700 | PubMed |
| 39456582 | Antibody-Based Therapies for Peripheral T-Cell Lymphoma. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39456582 | PubMed |
| 39363128 | Tumor necrosis factor superfamily signaling: life and death in cancer. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/39363128 | PubMed |
| 39247806 | Anti-TNFR2 Antibody-Conjugated PLGA Nanoparticles for Targeted Delivery of Adriamycin in Mouse Colon Cancer. | Research (Wash D C) | 2024 | https://conductscience.org/library/papers/39247806 | PubMed |
| 39223671 | Targeting TNFR2 for cancer immunotherapy: recent advances and future directions. | J Transl Med | 2024 | https://conductscience.org/library/papers/39223671 | PubMed |
| 38474115 | TNFRSF1B Gene Variants in Clinicopathological Aspects and Prognosis of Patients with Cutaneous Melanoma. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474115 | PubMed |
| 37958479 | Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37958479 | PubMed |
| 37935468 | Blockade of TNF-α/TNFR2 signalling suppresses colorectal cancer and enhances the efficacy of anti-PD1 immunotherapy by decreasing CCR8+T regulatory cells. | J Mol Cell Biol | 2024 | https://conductscience.org/library/papers/37935468 | PubMed |
| 37809067 | Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk. | Front Immunol | 2023 | https://conductscience.org/library/papers/37809067 | PubMed |
| 37589506 | TNFR2 promotes pancreatic cancer proliferation, migration, and invasion via the NF-κB signaling pathway. | Aging (Albany NY) | 2023 | https://conductscience.org/library/papers/37589506 | PubMed |
| 37553427 | The TNFα/TNFR2 axis mediates natural killer cell proliferation by promoting aerobic glycolysis. | Cell Mol Immunol | 2023 | https://conductscience.org/library/papers/37553427 | PubMed |
Genes36
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33907692
GET https://conductscience.org/api/papers/v1/33907692/references?page=2